EMA Authorised: Yentreve (duloxetine hydrochloride) — Eli Lilly Nederland B.V.

View source ↗

Summary

The European Medicines Agency authorized Yentreve (duloxetine hydrochloride) by Eli Lilly Nederland B.V. for stress urinary incontinence, with decision date 17 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Yentreve (duloxetine hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Urinary Incontinence, Stress. MAH: Eli Lilly Nederland B.V.. Decision date: 17/06/2024